Epigenetic dysregulation in Alzheimer's disease: Cause or consequence?

Epigenomics

Volumn 6, Issue 1, 2014, Pages 9-11

  Van Den Hove, Daniel LA ^a,b   Kenis, Gunter ^a   Rutten, Bart PF ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Alzheimer's disease; Biomarker; Blood; DNA hydroxymethylation; DNA methylation; Epigenetics

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; BRAIN FUNCTION; DEMENTIA; DNA METHYLATION; EPIGENETIC DYSREGULATION; EPIGENETICS; GENETIC DISORDER; GENETIC VARIABILITY; HISTONE MODIFICATION; MEMORY; NERVE CELL PLASTICITY; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

ALZHEIMER DISEASE; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; GENETIC MARKERS; GENOME, HUMAN; HUMANS;

EID: 84895489518     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.13.84     Document Type: Review

References (18)

1. Ferri CP, Prince M, Brayne C et al. Global prevalence of dementia: A Delphi consensus study. Lancet 366(9503), 2112-2117 (2005
2. Budson AE, Solomon PR. New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist. Pract. Neurol. 12(2), 88-96 (2013
3. Chouliaras L, Mastroeni D, Delvaux E et al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 34(9), 2091-2099 (2013
4. Iwata A, Nagata K, Hatsuta H et al. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation. Hum. Mol. Genet. doi:10.1093/hmg/ddt451 (2013
5. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation. Neurobiol Aging 31(12), 2025-2037 (2010
6. Lunnon K, Mill J. Epigenetic studies in Alzheimer's disease: Current findings, caveats, and considerations for future studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. doi:10.1002/ajmg.b.32201 (2013) (Epub ahead of print
7. Day JJ, Sweatt JD. Epigenetic mechanisms in cognition. Neuron 70(5), 813-829 (2011
8. Taher N, Mckenzie C, Garrett R, Baker M, Fox N, Isaacs GD. Amyloid-beta alters the DNA methylation status of cell-fate genes in an Alzheimer's disease model. J. Alzheimers Dis. 38(4), 831-844 (2013
9. Veerappan CS, Sleiman S, Coppola G. Epigenetics of Alzheimer's disease and frontotemporal dementia. Neurotherapeutics 10(4), 709-721 (2013
10. Bradley-Whitman MA, Lovell MA. Epigenetic changes in the progression of Alzheimer's disease. Mech. Ageing Dev. 134(10), 486-495 (2013
11. Barnes DE, Yaffe K, Byers AL, Mccormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer disease and vascular dementia. Arch. Gen. Psychiatry 69(5), 493-498 (2012
12. Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR. Does Alzheimer's disease begin in the brainstem? Neuropathol. Appl. Neurobiol. 35(6), 532-554 (2009
13. Rodriguez JJ, Noristani HN, Verkhratsky A. The serotonergic system in ageing and Alzheimer's disease. Prog. Neurobiol. 99(1), 15-41 (2012
14. Braak H, Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol. 121(2), 171-181 (2011
15. Davies MN, Volta M, Pidsley R et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 13(6), R43 (2012
16. Adwan L, Zawia NH. Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease. Pharmacol. Ther. 139(1), 41-50 (2013
17. van den Hove DL, Chouliaras L, Rutten BP. The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: Current status and prospects for future studies. Curr. Alzheimer Res. 9(5), 545-549 (2012
18. van den Hove DL, Kompotis K, Lardenoije R et al. Epigenetically regulated microRNAs in Alzheimer's disease. Neurobiol. Aging 35(4), 731-745 (2013